Type
Internal restructuring
Country
Germany
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

600 - 1,000 jobs
Number of planned job losses
Job loss
Announcement Date
16 September 2014
Employment effect (start)
1 January 2015
Foreseen end date
31 December 2018

Description

Pharmaceutical company Boehringer Ingelheim announced plans to cut up to 600 jobs in Germany by 2016. As reported, in the framework of a cost saving restructuring plan due to weak success of certain products and a decreasing turnover, the group announced its intention to cut approximately 1,000 jobs in Germany by the end of 2018 aiming at 15pc or € 450 million cost reduction. According to the sources, the company has started negotiations with the employee representatives and the final decision will be made by the end of 2014.

As mentioned by the company, most possibly there will be no forced redundancies and the measure will be based in hiring freeze and non-replacement of jobs lost through natural attrition. The sites in Dortmund and Hannover, as well as the biopharmaceutical production in Biberach and the production in Ingelheim will not be affected.

Boehringer Ingelheim has approximately 14,000 staff in Germany and 46,000 worldwide.


Sources

  • 17 September 2014: FAZ
  • 23 September 2014: FAZ
  • 16 September 2014: Handelsblatt
  • 17 September 2014: Handelsblatt

Citation

Eurofound (2014), Boehringer Ingelheim, Internal restructuring in Germany, factsheet number 77570, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/77570.